CHARLES WANKER: Open Payments
NPI 1609835446 · IOLA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 9 payments from 6 companies in 2025. Trend: 2023 $112 · 2024 $111 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ABBVIE INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, FARXIGA, VRAYLAR, JARDIANCE, REXULTI, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
